Loading data
CRSNYSE
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 3.12 bn USD | 2.88 bn USD | 2.76 bn USD | 2.55 bn USD | 1.84 bn USD |
| Gross profit | 955.5 m USD | 768.6 m USD | 584.3 m USD | 337.3 m USD | 149.8 m USD |
| Research and development expense | 27.7 m USD | 26.1 m USD | 25.6 m USD | 24.4 m USD | 20.4 m USD |
| Selling, general and administrative expense | 253.5 m USD | 243.2 m USD | 230.2 m USD | 204.2 m USD | 174.7 m USD |
| Operating profit | 702 m USD | 521.8 m USD | 323.1 m USD | 133.1 m USD | -24.9 m USD |
| Interest expense | — | — | — | 54.1 m USD | 44.9 m USD |
| Profit before tax | 656.2 m USD | 467.3 m USD | 211.6 m USD | 72.5 m USD | -63.1 m USD |
| Income tax expense | 126.4 m USD | 91.3 m USD | 25.1 m USD | 16.1 m USD | -14 m USD |
| Net income (reported basis) | 530 m USD | 376 m USD | 187 m USD | 56 m USD | -49 m USD |
| Basic earnings per share | 10.59 USD/share | 7.5 USD/share | 3.75 USD/share | 1.15 USD/share | -1.01 USD/share |
| Diluted earnings per share | 10.52 USD/share | 7.42 USD/share | 3.7 USD/share | 1.14 USD/share | -1.01 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.